Related Experiment Videos
Urticaria pigmentosa coexisting with multiple myeloma
G S Ogg1, J L Rosbotham, D M MacDonald
1St John's Institute of Dermatology, Guy's Hospital, London, UK.
Clinical and Experimental Dermatology
|September 1, 1996
Summary
Urticaria pigmentosa, a form of mast cell disease, can be linked to blood cancers. This case highlights a rare association between urticaria pigmentosa and multiple myeloma, suggesting screening for blood disorders.
Area of Science:
- Hematology
- Oncology
- Dermatology
Background:
- Mast cell disease encompasses conditions like urticaria pigmentosa.
- Mast cell disorders are known to associate with myeloid malignancies and lymphoproliferative disorders.
- The link between mast cell disease and multiple myeloma is not previously documented.
Observation:
- A 44-year-old male with a history of urticaria pigmentosa developed multiple myeloma.
- The multiple myeloma diagnosis was complicated by acute renal failure.
- The patient's urticaria pigmentosa began 8 years prior to the multiple myeloma diagnosis.
Findings:
- This case presents a novel association between urticaria pigmentosa and multiple myeloma.
- The patient's presentation suggests a potential, albeit rare, link between mast cell activation and plasma cell malignancies.
- Acute renal failure was a significant complication in this patient.
Implications:
- Patients with urticaria pigmentosa may require screening for hematological malignancies.
- Further research is warranted to explore the potential pathogenetic links between mast cell disorders and multiple myeloma.
- Early detection of hematological malignancies in patients with mast cell disease could improve patient outcomes.